Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

PaperCitations, authors & open-access status

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 531 citations, 2008 year and closed oa status.

531
Citations
2008
Year
closed
OA Status

Related on ScholarIQ

David W. Dodick
Author
Paul Winner
Author
The Lancet
Journal
Migraine and Headache Studies
Topic
Migraine and Headache Studies
Topic
Pain Management and Opioid Use
Topic
470M+ articles · free account